close

Enter

Log in using OpenID

Pediatric Clinical Trials Market

embed
Pediatric clinical trials play a major role in modern healthcare, as pediatric clinical trials are the only criteria to launch new drugs in market for various indications that affect pediatric population and therefore pharmaceutical and biotechnolog
Pediatric Clinical Trials Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,
AND OPPORTUNITY ANALYSIS, 2018-2026
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Pediatric Clinical Trials Market – Overview
Clinical trials are the gold standard and must for generating evidence-based data and knowledge in medicine. Clinical
trials conducted on children (between age group of 0 to 18) for research and development of drugs or formation of new
drugs are called as pediatric clinical trials. Pharmaceuticals and biotechnological industries and government regulatory
bodies are collectively focused on improving research and development for pediatrics population. A new law in the U.S.
and Europe was passed as pediatric regulation 2007 that required new adult drugs to be tested for use in children.
Robust product pipeline, increasing approval of new pediatric drugs and high outsourcing for drug development are
major factors driving pediatric clinical trials market growth. According to Pharmaceutical Research and Manufacturers’
Association (PHRMA) data in 2018, over 1,300 industry-sponsored pediatric clinical trials are underway across a variety
of therapeutic areas, including diseases where there is significant unmet need such as infectious diseases, neurologic
conditions, genetic disorders, and several forms of cancer.
Increasing number of drugs under clinical stage of development in order to cater to unmet medical needs for pediatric
patient population is expected to boost the market growth. According to Pharmaceutical Research and Manufacturers’
Association (PHRMA) data in 2018, over 1,300 industry-sponsored pediatric clinical trials are underway across a variety
of therapeutic areas, including diseases where there is significant unmet need such infectious diseases, neurologic
conditions, genetic disorders, and several forms of cancer.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Pediatric Clinical Trials Market Taxonomy:
By Clinical Trial Phase:
●
Pre-clinical
●
Phase I
●
Phase II
●
Phase III
By Study Design:
●
Interventional
●
Observational
By Medical Condition:
●
Neuropsychiatric Conditions
●
Infectious Diseases
●
Maternal and Perinatal Conditions
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/397
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Pediatric Clinical Trials Market: Key Players
●
Syneos Health Inc. *.
●
IQVIA Holdings, Inc.
●
Charles River Laboratories International Inc.
●
Covance Inc.
●
ICON plc.
●
Pharmaceutical Product Development, LLC.
●
Genentech (F. Hoffmann-La Roche AG).
●
Pfizer, Inc.
●
Bristol - Myers Squibb.
View this report @
https://www.coherentmarketinsights.com/market-insight/pediatric-clinical-trials-market-397
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization
focused on assisting its plethora of clients achieve transformational growth by helping
them make critical business decisions. We are headquartered in India, with an office at
the global financial capital in the U.S. Our client base includes players from across all
business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various
recommendations about operational improvements, technologies, emerging market
trends and new working methods. We offer both customized and syndicated market
research reports that help our clients create visionary growth plans to provide traction to
their business. We meticulously study emerging trends across various industries at both
the global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
SECTOR COVERAGE
Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARC
H
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our
clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained
growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
To k no w mor e abo ut us , v is it o ur w eb site:
w ww.coh er en tmark etins ig hts.com
THANK YOU
© Coherent market Insights. All Rights Reserved
F or s ales q ueries o r new top ics email u s o n :
s [email protected] er en tmark etins ig hts .co m
Fo r o th er q uer ies co n tact:
Mr. Sh ah
( Man ag er - Bus iness D ev elo pment)
Co herent Mark et Ins ig hts
s [email protected] er en tmark etins ig hts .co m
+1 -2 06 -7 0 1- 67 02
1/--pages
Report inappropriate content